Intranasal fluticasone furoate +/- intraocular olopatadine vs intraocular olopatadine alone in seasonal allergic rhinitis patients undergoing nasal allergan challenge

Trial Profile

Intranasal fluticasone furoate +/- intraocular olopatadine vs intraocular olopatadine alone in seasonal allergic rhinitis patients undergoing nasal allergan challenge

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Mar 2012

At a glance

  • Drugs Fluticasone furoate (Primary) ; Olopatadine (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Mar 2012 Results presented at the 68th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
    • 06 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top